US Edition
J&J, Lilly and GSK to Refund 340B Covered Entities for Overcharges - 340B Report
Summary by 340breport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
J&J, Lilly and GSK to Refund 340B Covered Entities for Overcharges - 340B Report
Three major drugmakers recently announced refunds for 340B covered entities that purchased certain drugs in 2022 and 2023 following recalculations [...] The post J&J, Lilly and GSK to Refund 340B Covered Entities for Overcharges appeared first on 340B Report.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
